Hyloris Pharmaceuticals SA 2025 Sustainability Report
Company: Hyloris Pharmaceuticals SA
Sector: Manufacturing
Country: Belgium
Year: 2025
Type: Sustainability Report
Pages: 15
The report describes Hyloris's voluntary approach to addressing most CSRD/ESRS topics and its focus on health, environmental sustainability, and responsible governance. It reports a workforce of 55 people across 12 countries, with a 56% male and 44% female organizational representation and two women among seven board directors. Environmental initiatives include environmental risk assessments for new medicines, a BREEAM-rated headquarters, and a transition toward hybrid and fully electric vehicles. The report also highlights a 2025 external review of corporate governance and the implementation of additional compliance and oversight measures.
Indicators available in this report: